Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study).
Saved in:
| Title: | Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study). |
|---|---|
| Authors: | Nguyen-Khac F; Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France., Baron M; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France., Guièze R; Hematology Department, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France., Feugier P; Department of Hematology, University Hospital of Nancy, Nancy, France., Fayault A; FILO, Tours University Hospital, Tours, France., Raynaud S; Laboratory of Hematology, University Hospital of Nice, Nice, France., Troussard X; Laboratory of Hematology, CHU Caen Normandie, Caen, France., Droin N; Inserm U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Damm F; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany., Smagghe L; Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France., Susin S; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France., Leblond V; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France., Dartigeas C; Department of Hematology, CHU Tours, Hôpital Bretonneau, Tours, France., Van den Neste E; Department of Hematology, Cliniques Universitaires Université Catholique de Louvain Saint-Luc, Bruxelles, Belgium., Leprêtre S; Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France., Bernard OA; Inserm U1170, Université Paris-Saclay, Gustave Roussy Cancer Campus, Villejuif, France., Roos-Weil D; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France. |
| Corporate Authors: | on behalf the FILO (French Innovative Leukaemia Organization) Group |
| Source: | British journal of haematology [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 495-502. Date of Electronic Publication: 2024 Apr 23. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38654616 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nguyen-Khac+F%22">Nguyen-Khac F</searchLink>; Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.<br /><searchLink fieldCode="AU" term="%22Baron+M%22">Baron M</searchLink>; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Guièze+R%22">Guièze R</searchLink>; Hematology Department, Clermont-Ferrand University Hospital, Clermont Auvergne University, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Feugier+P%22">Feugier P</searchLink>; Department of Hematology, University Hospital of Nancy, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Fayault+A%22">Fayault A</searchLink>; FILO, Tours University Hospital, Tours, France.<br /><searchLink fieldCode="AU" term="%22Raynaud+S%22">Raynaud S</searchLink>; Laboratory of Hematology, University Hospital of Nice, Nice, France.<br /><searchLink fieldCode="AU" term="%22Troussard+X%22">Troussard X</searchLink>; Laboratory of Hematology, CHU Caen Normandie, Caen, France.<br /><searchLink fieldCode="AU" term="%22Droin+N%22">Droin N</searchLink>; Inserm U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Damm+F%22">Damm F</searchLink>; Department of Hematology, Oncology, and Cancer Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Zu Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Smagghe+L%22">Smagghe L</searchLink>; Unité de Cytogénétique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Susin+S%22">Susin S</searchLink>; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.<br /><searchLink fieldCode="AU" term="%22Leblond+V%22">Leblond V</searchLink>; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dartigeas+C%22">Dartigeas C</searchLink>; Department of Hematology, CHU Tours, Hôpital Bretonneau, Tours, France.<br /><searchLink fieldCode="AU" term="%22Van+den+Neste+E%22">Van den Neste E</searchLink>; Department of Hematology, Cliniques Universitaires Université Catholique de Louvain Saint-Luc, Bruxelles, Belgium.<br /><searchLink fieldCode="AU" term="%22Leprêtre+S%22">Leprêtre S</searchLink>; Department of Clinical Hematology, Centre Henri Becquerel, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Bernard+OA%22">Bernard OA</searchLink>; Inserm U1170, Université Paris-Saclay, Gustave Roussy Cancer Campus, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Roos-Weil+D%22">Roos-Weil D</searchLink>; Cell Death and Drug Resistance in Lymphoproliferative Disorders Team, Centre de Recherche Des Cordeliers, INSERM, Sorbonne Université, Université Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Paris, France.; Service d'Hématologie Clinique, Hôpital Pitié-Salpêtrière, APHP, Sorbonne Université, Paris, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22on+behalf+the+FILO+%28French+Innovative+Leukaemia+Organization%29+Group%22">on behalf the FILO (French Innovative Leukaemia Organization) Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220372544%22">British journal of haematology</searchLink> [Br J Haematol] 2024 Aug; Vol. 205 (2), pp. 495-502. <i>Date of Electronic Publication: </i>2024 Apr 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0372544 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2141 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200071048%22">00071048 </searchLink><i>NLM ISO Abbreviation: </i>Br J Haematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38654616 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/bjh.19459 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 495 Titles: – TitleFull: Prognostic impact of genetic abnormalities in 536 first-line chronic lymphocytic leukaemia patients without 17p deletion treated with chemoimmunotherapy in two prospective trials: Focus on IGHV-mutated subgroups (a FILO study). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nguyen-Khac F – PersonEntity: Name: NameFull: Baron M – PersonEntity: Name: NameFull: Guièze R – PersonEntity: Name: NameFull: Feugier P – PersonEntity: Name: NameFull: Fayault A – PersonEntity: Name: NameFull: Raynaud S – PersonEntity: Name: NameFull: Troussard X – PersonEntity: Name: NameFull: Droin N – PersonEntity: Name: NameFull: Damm F – PersonEntity: Name: NameFull: Smagghe L – PersonEntity: Name: NameFull: Susin S – PersonEntity: Name: NameFull: Leblond V – PersonEntity: Name: NameFull: Dartigeas C – PersonEntity: Name: NameFull: Van den Neste E – PersonEntity: Name: NameFull: Leprêtre S – PersonEntity: Name: NameFull: Bernard OA – PersonEntity: Name: NameFull: Roos-Weil D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2024 Aug Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1365-2141 Numbering: – Type: volume Value: 205 – Type: issue Value: 2 Titles: – TitleFull: British journal of haematology Type: main |
| ResultId | 1 |
